lncRNA-PDPK2P promotes hepatocellular carcinoma progression through the PDK1/AKT/Caspase 3 pathway.
Pan W, Li W, Zhao J, Huang Z, Zhao J, Chen S, Wang C, Xue Y, Huang F, Fang Q, Wang J, Brand D, Zheng SG.
Pan W, et al. Among authors: wang j, wang c.
Mol Oncol. 2019 Oct;13(10):2246-2258. doi: 10.1002/1878-0261.12553. Epub 2019 Aug 22.
Mol Oncol. 2019.
PMID: 31368655
Free PMC article.